Literature DB >> 12149319

Transmission of drug-resistant tuberculosis in Texas and Mexico.

Teresa N Quitugua1, Barbara J Seaworth, Stephen E Weis, Jeffery P Taylor, J Seb Gillette, Ishmael I Rosas, Kenneth C Jost, D Mitchel Magee, Rebecca A Cox.   

Abstract

To examine the transmission of drug-resistant (DR) tuberculosis between Texas and Mexico, Mycobacterium tuberculosis isolates resistant to one or more of the first-line antimycobacterial drugs were obtained from 606 patients who resided in Texas and 313 patients who resided in Mexico, primarily within the state of Tamaulipas. The isolates were genotyped by IS6110-based restriction fragment length polymorphism (RFLP) analysis and spoligotyping. Of the 919 isolates genotyped, 413 (45%) grouped into 105 clusters containing 2 or more isolates with identical genotypes. In addition to having identical genotypes, identical drug resistance patterns were identified in 250 isolates in 78 clusters (DR clusters). Twenty DR clusters, containing isolates from 32% of the total number of patients infected with DR strains, were geographically distributed across Mexico and Texas. Within this population of 919 patients infected with DR isolates, the probability of being in a DR cluster was the same for residents of Mexico and Texas. In Texas, the significant independent predictors of clustering within DR clusters as opposed to genotype clusters were found to be race, age, country of birth, human immunodeficiency virus (HIV) infection status, and resistance to more than one drug. Specifically, isolates from African Americans, individuals under age 65, individuals born in the United States, and HIV-positive individuals were each more likely to be associated with a DR cluster. By contrast, no significant independent predictors of clustering in a DR cluster were identified in Mexico. Although some DR M. tuberculosis strains are geographically restricted, this study suggests that a number of strains are transmitted between Mexico and the United States.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12149319      PMCID: PMC120686          DOI: 10.1128/JCM.40.8.2716-2724.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997.

Authors:  D van Soolingen; M W Borgdorff; P E de Haas; M M Sebek; J Veen; M Dessens; K Kremer; J D van Embden
Journal:  J Infect Dis       Date:  1999-09       Impact factor: 5.226

2.  Population-based survey for drug resistance of tuberculosis--Mexico, 1997.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1998-05-15       Impact factor: 17.586

3.  Tuberculosis in Mexican-born persons in San Francisco: reactivation, acquired infection and transmission.

Authors:  R M Jasmer; A Ponce de Leon; P C Hopewell; R G Alarcon; A R Moss; E A Paz; G F Schecter; P M Small
Journal:  Int J Tuberc Lung Dis       Date:  1997-12       Impact factor: 2.373

4.  A study of tuberculosis among foreign-born Hispanic persons in the U.S. States bordering Mexico.

Authors:  C D Wells; M Ocaña; K Moser; D Bergmire-Sweat; J C Mohle-Boetani; N J Binkin
Journal:  Am J Respir Crit Care Med       Date:  1999-03       Impact factor: 21.405

5.  Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology.

Authors:  J Kamerbeek; L Schouls; A Kolk; M van Agterveld; D van Soolingen; S Kuijper; A Bunschoten; H Molhuizen; R Shaw; M Goyal; J van Embden
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

6.  Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility.

Authors:  K Kremer; D van Soolingen; R Frothingham; W H Haas; P W Hermans; C Martín; P Palittapongarnpim; B B Plikaytis; L W Riley; M A Yakrus; J M Musser; J D van Embden
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

7.  Complex transmission dynamics of clonally related virulent Mycobacterium tuberculosis associated with barhopping by predominantly human immunodeficiency virus-positive gay men.

Authors:  A Yaganehdoost; E A Graviss; M W Ross; G J Adams; S Ramaswamy; A Wanger; R Frothingham; H Soini; J M Musser
Journal:  J Infect Dis       Date:  1999-10       Impact factor: 5.226

8.  Evidence from molecular fingerprinting of limited spread of drug-resistant tuberculosis in Texas.

Authors:  R W Wilson; Z Yang; M Kelley; M D Cave; J M Pogoda; R J Wallace; J P Cegielski; D F Dunbar; D Bergmire-Sweat; L B Elliott; P F Barnes
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

9.  Epidemiology of drug-resistant tuberculosis in Texas.

Authors:  J P Taylor; D Bergmire-Sweat; L Suarez
Journal:  Am J Epidemiol       Date:  1999-02-15       Impact factor: 4.897

10.  Tuberculosis among foreign-born persons who had recently arrived in the United States--Hawaii, 1992-1993, and Los Angeles County, 1993.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-09-29       Impact factor: 17.586

View more
  18 in total

1.  Continued low rates of transmission of Mycobacterium tuberculosis in Norway.

Authors:  Ulf R Dahle; Per Sandven; Einar Heldal; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

2.  Analysis of Mycobacterium tuberculosis genotypes in Madrid and identification of two new families specific to Spain-related settings.

Authors:  Darío García de Viedma; Emilio Bouza; Nalin Rastogi; Christophe Sola
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

3.  Genetic diversity of Mycobacterium tuberculosis in Mbarara, South Western Uganda.

Authors:  J Bazira; M Matte; B B Asiimwe; L M Joloba
Journal:  Afr Health Sci       Date:  2010-12       Impact factor: 0.927

4.  Detection of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis using denaturing gradient gel electrophoresis.

Authors:  Mark T McCammon; John S Gillette; Derek P Thomas; Srinivas V Ramaswamy; Edward A Graviss; Barry N Kreiswirth; Jan Vijg; Teresa N Quitugua
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

5.  Detection by denaturing gradient gel electrophoresis of pncA mutations associated with pyrazinamide resistance in Mycobacterium tuberculosis isolates from the United States-Mexico border region.

Authors:  Mark T McCammon; John S Gillette; Derek P Thomas; Srinivas V Ramaswamy; Ishmael I Rosas; Edward A Graviss; Jan Vijg; Teresa N Quitugua
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

6.  First insights into the genetic diversity of Mycobacterium tuberculosis isolates from HIV-infected Mexican patients and mutations causing multidrug resistance.

Authors:  Rocio Lopez-Alvarez; Claudia Badillo-Lopez; Jorge F Cerna-Cortes; Ivan Castillo-Ramirez; Sandra Rivera-Gutierrez; Addy C Helguera-Repetto; Diana Aguilar; Rogelio Hernandez-Pando; Sofia Samper; Jorge A Gonzalez-y-Merchand
Journal:  BMC Microbiol       Date:  2010-03-17       Impact factor: 3.605

7.  Mycobacterium tuberculosis spoligotypes in Monterrey, Mexico.

Authors:  Carmen A Molina-Torres; Elisa Moreno-Torres; Jorge Ocampo-Candiani; Adrian Rendon; Kym Blackwood; Kristin Kremer; Nalin Rastogi; Oliverio Welsh; Lucio Vera-Cabrera
Journal:  J Clin Microbiol       Date:  2009-11-25       Impact factor: 5.948

8.  Influences of cross-border mobility on tuberculosis diagnoses and treatment interruption among injection drug users in Tijuana, Mexico.

Authors:  Robert Deiss; Richard S Garfein; Remedios Lozada; Jose Luis Burgos; Kimberly C Brouwer; Kathleen S Moser; Maria Luisa Zuniga; Timothy C Rodwell; Victoria D Ojeda; Steffanie A Strathdee
Journal:  Am J Public Health       Date:  2009-06-18       Impact factor: 9.308

9.  Molecular typing of Mycobacterium tuberculosis by using nine novel variable-number tandem repeats across the Beijing family and low-copy-number IS6110 isolates.

Authors:  R Scott Spurgiesz; Teresa N Quitugua; Kimothy L Smith; James Schupp; Eldon G Palmer; Rebecca A Cox; Paul Keim
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

10.  Does directly observed therapy (DOT) reduce drug resistant tuberculosis?

Authors:  Patrick K Moonan; Teresa N Quitugua; Janice M Pogoda; Gary Woo; Gerry Drewyer; Behzad Sahbazian; Denise Dunbar; Kenneth C Jost; Charles Wallace; Stephen E Weis
Journal:  BMC Public Health       Date:  2011-01-07       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.